News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UCB SA Subsidiary, Schwarz Pharma, To Pay $22M In False Claims Settlement


4/30/2010 8:17:37 AM

Wall Street Journal -- WASHINGTON (Dow Jones)--UCB SA (UCB.BT) subsidiary Schwarz Pharma Inc. will pay $22 million to settle allegations that it failed to notify the U.S. government that two of its drugs didn't qualify for coverage under federal health-care programs, the U.S. Justice Department announced Thursday.

Read at Boston Herald
Read at AP
Read at Injuryboard.com
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES